DOP2006000004A - HETEROAROMATIC QUINOLINE COMPOUNDS. - Google Patents

HETEROAROMATIC QUINOLINE COMPOUNDS.

Info

Publication number
DOP2006000004A
DOP2006000004A DO2006000004A DO2006000004A DOP2006000004A DO P2006000004 A DOP2006000004 A DO P2006000004A DO 2006000004 A DO2006000004 A DO 2006000004A DO 2006000004 A DO2006000004 A DO 2006000004A DO P2006000004 A DOP2006000004 A DO P2006000004A
Authority
DO
Dominican Republic
Prior art keywords
compounds
relates
quinoline compounds
heteroaromatic
heteroaromatic quinoline
Prior art date
Application number
DO2006000004A
Other languages
Spanish (es)
Inventor
John Michael Humphrey
Christopher John Helal
Patrick Robert Verhoest
Dennis Jay Hoover
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44340249&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DOP2006000004(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to DO2006000004A priority Critical patent/DOP2006000004A/en
Publication of DOP2006000004A publication Critical patent/DOP2006000004A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere a compuestos heteroaromáticos que sirven como inhibidoes de fosfodiesterasa (PDE) eficaces. En particular, la invención se refiere a dicho compuestos que son inhibidores selectivos de PDE10. La invención también se refiere a intermedios para la preparación de dichos compuestos; a compociciones farmacéuticas que comprenden dichos compuestos; y al uso de dichos compuestos en un procedimiento para tratar cierto trastornos del sistema nervioso central (SNC) u otros trastornos.The invention relates to heteroaromatic compounds that serve as effective phosphodiesterase (PDE) inhibitors. In particular, the invention relates to said compounds that are selective PDE10 inhibitors. The invention also relates to intermediates for the preparation of said compounds; to pharmaceutical compositions comprising said compounds; and to the use of said compounds in a procedure to treat certain disorders of the central nervous system (CNS) or other disorders.

DO2006000004A 2000-05-17 2000-05-17 HETEROAROMATIC QUINOLINE COMPOUNDS. DOP2006000004A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DO2006000004A DOP2006000004A (en) 2000-05-17 2000-05-17 HETEROAROMATIC QUINOLINE COMPOUNDS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DO2006000004A DOP2006000004A (en) 2000-05-17 2000-05-17 HETEROAROMATIC QUINOLINE COMPOUNDS.

Publications (1)

Publication Number Publication Date
DOP2006000004A true DOP2006000004A (en) 2006-07-15

Family

ID=44340249

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2006000004A DOP2006000004A (en) 2000-05-17 2000-05-17 HETEROAROMATIC QUINOLINE COMPOUNDS.

Country Status (1)

Country Link
DO (1) DOP2006000004A (en)

Similar Documents

Publication Publication Date Title
CR9180A (en) HETEROAROMATIC QUINOLINE COMPOUNDS
UY28750A1 (en) TETRAHYDROISOQUINOLINYL DERIVATIVES OF QUINAZOLINE AND ISOQUINOLINE
UY29028A1 (en) NEW PIPERIDILO DERIVATIVES OF QUINAZOLINA AND ISOQUINOLINA
CR9135A (en) NOVEDOUS PIRROLIDILE DERIVATIVES OF HETEROAROMATIC COMPOUNDS
BR0016693A (en) Pyrrolidine derivatives as cyclic amp specific phosphodiesterase inhibitors
PT1242415E (en) 3-TIAZOL-4-IL-PYRROLIDINE DERIVATIVES AS MFA-SPECIFIED PHOSPHODIESTERASE INHIBITORS
HN2001000006A (en) CORTICOTROPINE RELEASE FACTOR ANTAGONISTS
UY24799A1 (en) 6-PHENYLPIRIDYL-2-AMINE DERIVATIVES
UY30080A1 (en) BICYCLE HETEROARILO COMPOUNDS AS PDE10 INHIBITORS
NO950879L (en) 3-phenylpyrrolidine derivatives
BR0016687A (en) Pyrrolidines that inhibit ampc specific powder
DK1377586T3 (en) Tricyclic diazepines as tocolytic oxytocin receptor antagonists
PA8446301A1 (en) 2-AMINO-6- (4-PHENOXI-2-SUBSTITUTED) -PIRIDINES SUBSTITUTED
GB0320320D0 (en) Novel compounds
WO2002051848A3 (en) Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
DE60018470D1 (en) CYCLIC AMP SPECIFIC PHOSPHODIESTERASE INHIBITORS
DOP2006000004A (en) HETEROAROMATIC QUINOLINE COMPOUNDS.
PA8653001A1 (en) AZANBENZOXAZOLES FOR THE TREATMENT OF CNS DISORDERS
DOP2005000139A (en) NEW DERIVATIVES PIPERIDILO DO QUINAZOLINA AND ISOQUINOLINA
ECSP992961A (en) NEW PHARMACEUTICAL COMPOSITIONS